Comprehensive Biomarker Testing for Lung Cancer: Who Needs It & What’s It For?

Medically Reviewed

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles
6) Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated September 21st, 2022

Comprehensive Biomarker Testing for Lung Cancer: Who Needs It & What’s It For?

Comprehensive biomarker testing is genetic testing of a lung tumor that tells doctors whether targeted therapy will work.

NOW
PLAYING
Actor Chris Hemsworth Just Learned He Has 8X Greater Chance of Getting Alzheimer's-- How Valuable Is Genetic Testing For Major Diseases?
NOW
PLAYING
How to Treat Triple-Negative Breast Cancer: Keytruda Shows Promising Boost in Survival
NOW
PLAYING
Newly-Approved Libtayo-Chemotherapy Combination for Advanced Lung Cancer Shows Promise for Patients With Limited Options
NOW
PLAYING
Gone at 51-Years-old, The Beach Boy's Carl Wilson Fought Lung Cancer-- Celebrating His Life & Tremendous Progress For This Disease
NOW
PLAYING
Could Detecting Cancer Early Through Blood Testing Be The Future?
NOW
PLAYING
A New Study Questions the Effectiveness of Colonoscopies — But Specialists Reinforce its Importance

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... lung cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

Later Stage Treatment: The Importance of Biomarker Testing

SEE MORE   

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.

Later Stage Treatment: The Importance of Biomarker Testing

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.